Powered by

Oxford Immunotec Reports Second Quarter 2019 Financial Results

Aug 06, 2019 - GlobeNewswire

Second quarter revenue of $19.6 million, an increase of 18% compared to prior year periodGross margin of 72.4%, reflecting our shift towards a pure-play kit businessPositive net income of $0.6 million compared to a net loss of $6.5 million in prior year period

OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), or the Company, a global, high-growth diagnostics company, today announced second quarter 2019 financial r...